Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older (men and women are both welcome)
- You have been diagnosed with mild or moderate ulcerative colitis (UC), confirmed by a camera examination of the bowel (endoscopy)
- You are currently being treated with a medication called mesalamine (also known as 5-aminosalicylic acid)
Who may not be able to join:
- You have severe ulcerative colitis
- You have significant problems with your liver or kidney function
- You have diabetes
- You have colorectal (bowel) cancer
- You are using steroid medications, either as a suppository/enema or taken by mouth or injection
- You are taking medications that suppress the immune system or biological therapies
- You have an addiction to alcohol or drugs
- You have a known allergy to any of the medications being studied in this trial
- You have had surgery to remove all or part of your large bowel (colon)
- You have heart failure, irregular heartbeat, or any history of heart disease including angina or heart attack
- You have another inflammatory condition or an active infection
- You have chronic obstructive pulmonary disease (COPD) or severe obesity (confirm with trial site)
- You have a liver disease
- You have low platelet or low white blood cell counts (confirm with trial site)
- You have any type of seizures or epilepsy
- You have kidney disease
- You have a blood clotting disorder
- You are currently taking a medication called metronidazole (an antibiotic)
- You have a known allergy to mebendazole, albendazole, or related medications called benzimidazoles
- You are currently taking antioxidant supplements or medications
- You are pregnant or breastfeeding
- You are taking certain other medications including warfarin, low-dose aspirin, clopidogrel, phenytoin, carbamazepine, or valproate (confirm with trial site for the full list)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
change in disease activity; change in Partial Mayo Scoring Index (PMSI) assessment for Ulcerative Colitis Activity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.